and the 3Department of Rheumatology, Sahlgren's Hospital, S-413 45 Gothenburg, Sweden SUMMARY The activity of superoxide dismutase isoenzymes was determined in knee joint synovial fluid from 21 patients with rheumatoid arthritis, nine patients with reactive arthritides, and from 17 patients before arthroscopy or arthrotomy for suspected meniscal or ligament injury (controls). Extracellular superoxide dismutase was the major isoenzyme and accounted for about 80% of the total superoxide dismutase activity in the controls. The pattern of the superoxide dismutase isoenzymes was significantly different in rheumatoid arthritis, extracellular (EC) superoxide dismutase being half, CuZn superoxide dismutase double, and the total superoxide dismutase activity a third lower than the activity in the synovial fluid of the controls. The superoxide dismutase activities were similar in synovial fluid from the controls and from the patients with reactive arthritides. The total superoxide dismutase activity was almost three times higher in control synovial fluid than in normal human plasma, but 300 times lower than in human tissues.
There is evidence to suggest that toxic oxygen reduction products are involved in the pathogenesis of inflammatory joint disease. Arthritic joints contain large amounts of granulocytes and monocytes, which have the potential to produce superoxide radicals and hydrogen peroxide upon activation.' The toxicity of these intermediates is greatly amplified by iron through hydroxyl radical formation. Moreover, there is an increased content of iron in synovial fluid (SF) from patients with rheumatoid arthritis (RA), 4and parenteral desferrioxamine has been shown to reduce the activity of experimental inflammatory joint disease.5 Exposure of human IgG in vitro to oxy radicals results in the formation of fluorescent aggregates. Similar aggregates can be isolated from fresh SF from RA patients.6 Exposure to superoxide radical and hydrogen peroxide in vitro leads to degradation of hyaluronic acid,7 collagen,8 and also cartilage constituents.9 10 Since it has been shown that superoxide dismutase (SOD; EC 1.15. of carbohydrate.1 Before separation, the viscosity of the specimen was reduced by treatment with hyaluronidase (10 units/ml) for 10 min at 37°C. The treatment had no adverse effect on the isoenzymes, and compensation was made for the small SOD activity in the hyaluronidase preparation. SF (0.5 ml) was applied to a 3 ml Con A-Sepharose column equilibrated with 10 mM potassium phosphate in 120 mM NaCl (pH 6.5). To allow adsorption of the sample along the length of the column 0-5 ml buffer was added three times at five minute intervals, and then the column was eluted with 2-5 ml buffer. The eluting fluid from the SF and buffer additions 
was collected and contained the CuZn SOD and Mn SOD of the sample. The column was washed with 40 ml of the phosphate buffer, and EC SOD was then eluted with 10 ml of 150 mM a-methyl-D-mannoside in 50 mM sodium phosphate (pH 6.5) added in 2 ml aliquots at five minute intervals. The column was regenerated with 10 ml 0-5 M a-methyl-Dmannoside followed by 40 ml 10 mM potassium phosphate in 120 mM NaCl (pH 6.5). The The SOD activity eluted with a-methyl-Dmannoside was completely adsorbed by anti-EC SOD and was not affected by anti-CuZn SOD, confirming that this activity is given by EC SOD. Most of the cyanide sensitive SOD activity which did not bind to Con A-Sepharose was adsorbed by anti-CuZn SOD, but about 7% (mean of four experiments) of the SOD activity which did not bind to Con A-Sepharose was adsorbed by anti-EC SOD, indicating that the attachment of EC SOD during the procedure was not fully complete. The figures presented for CuZn SOD will therefore include some EC SOD and will be somewhat too high and those for EC SOD somewhat too low.
COMPENSATION FOR CuZn SOD CONTRIBUTED BY HAEMOLYSED ERYTHROCYTES
A few of the control SFs were weakly reddish because of the presence of haemoglobin. The haemoglobin probably originated from bleeding caused by the puncture for collection of the fluids. In these samples the haemoglobin content was determined17 and the results used for calculation of CuZn SOD contributed by haemolysed erythrocytes using the mean CuZn SOD activity per milligram haemoglobin of normal erythrocytes. 8 The results were subtracted from the CuZn SOD activity found in the fluids.
SOD ISOENZYMES IN HUMAN PLASMA
Plasma was obtained from 16 healthy controls using heparin as anticoagulant. The isoenzyme composition was assessed using antibodies towards CuZn SOD and EC SOD immobilised on Sepharose 4B. 16 The plasma specimens were incubated overnight at 4°C with (a) Sepharose 4B (sham incubation), or (b) anti-CuZn SOD-Sepharose 4B, or (c) anti-CuZn SOD-Sepharose 4B+anti-EC SOD-Sepharose 4B. After centrifugation the SOD activity remaining in the supematants was determined. The CuZn SOD activity was taken as (a) minus (b) and the EC SOD activity as (b) minus (c). The Mn SOD activity was estimated from the cyanide resistant activity of supematant (c).
PROTEIN ANALYSIS
For protein analysis Coomassie brilliant blue G-250 was used.19 Human serum albumin was used for standardisation.
Results Table 1 shows the results of analysis of SOD activity in the SFs. Data for human plasma are presented for comparison. The major SOD isoenzyme in SF from all groups was EC SOD. The EC SOD activity in SF from the controls and from the ReA patients was not significantly different, but both were higher than the activity in fluids from RA patients. The plasma EC SOD activity was lower than the activity in SF from all groups.
The CuZn SOD activity in SF from controls and from patients with ReA did not differ significantly, but the values were clearly lower than in SF from RA patients. The CuZn SOD activity in SF from all groups was higher than the CuZn SOD activity in normal human plasma ( Table 1) .
The cyanide resistant SOD activity was a little lower in the SFs from patients with arthritis. All or part of the activity was probably given by Mn SOD, but since the activity is very low much fluid has to be added during SOD assay and various types of unspecific scavenging of superoxide radical might have contributed to the measured activity. The difference between the groups is therefore difficult to evaluate.
The total SOD activity of the SFs was two to three times greater than the total SOD activity in human plasma.
A few SF samples were assayed from patients with ankylosing spondylitis, gout, psoriatic arthropathy, and pyrophosphate arthritis ( Table 1 ). The results suggest that no major deviations in activity exist in these groups compared with the controls and the other arthritide groups.
Discussion
The CuZn SOD and Mn SOD are mainly found in cells and tissues, and the minor activity in plasma or other extracellular fluids is probably due to cellular leakage.20 21 The EC SOD activity in tissues is much lower than the activity of the other isoenzymes, and since it is the major isoenzyme in plasma and lymph an extracellular role for EC SOD has been suggested.2>22 In this study EC SOD was found to be the isoenzyme of highest activity present in non-inflammatory SFs. Moreover, the activity of this isoenzyme and of CuZn SOD was greater in control SFs than in normal human plasma.
The source ofEC SOD remains to be identified ,20 21 and the significant decrease of this isoenzyme activity in the RA SFs compared with control and ReA SFs is at present difficult to explain. A dilution effect cannot be ruled out, and inactivation by hydrogen peroxide'6 from activated granulocytes is another possibility. Nevertheless, a reduction in EC SOD activity would increase the susceptibility of SF and cartilage components in the joints of RA patients to damage by oxy radicals. The mean EC SOD activity in SFs of ReA patients was similar to that of controls.
The isoenzyme of second highest activity in all SFs was CuZn SOD. Its increased activity in rheumatoid SFs suggests an increased leakage from tissue damage and possibly from the haemorrhages in the synovial membranes. The considerable range of CuZn SOD activity in control SFs may partly be due to difficulties in separating cells and debris by centrifugation of the highly viscous normal SFs.
Previous studies of total SOD activity in SF using indirect methods have reported contradictory results. With a xanthine oxidase nitroblue tetrazolium assay no SOD activity was found in SF,23 but analyses with the xanthine oxidase/cytochrome c assay14 have resulted in approximately 10-fold24 and twofold25 higher activities in SF than found by us. Indirect SOD assays are liable to unspecific interferences with the superoxide producing and detecting systems and are relatively unsensitive, which makes the assay of the low SOD activity in SF ambiguous. With the very sensitive direct method of our study no remaining cyanide sensitive SOD activity was found after exposure of SF to immobilised antibodies towards CuZn SOD and EC SOD (data not presented). This shows the specificity of the method used and probably explains the difference between our results and previous findings.
Although the total SOD activity in SF is about three times higher than that of plasma, the activity is still low. The SOD concentration of human tissues is about 300 times higher than that of SF,22 but the SOD activity in SF is still potentially important. If the rate of SOD catalysed dismutation in SF is compared with the rate of spontaneous dismutation at pH 7*426 it is found that the SOD catalysed reaction is about 100 times faster at 1 FIM superoxide radical and 100 000 times faster at 1 nM superoxide radical. The situation in the joints is of course more complex than that described in the above comparison, with ascorbate and other reductants, ferric iron, and other substances competing for the superoxide radicals. Thera eutic use of 4-8 mg CuZn SOD intra-articularly, corresponding to 106 units SOD activity, will considerably increase the SF SOD activity. 
